Background {#Sec1}
==========

Infected osteoradionecrosis (IORN) is still one of the major problems after radiotherapy for neoplasms in the oral cavity. The chewing and swallowing functions of the patients are impaired, long-lasting conservative and surgical interventions may become necessary. In the last decades, there was an ample discussion about potential risk factors for the development of IORN. Besides the kind of surgical procedures, dosage and fractionation of radiotherapy and the simultaneous application of chemotherapy, the patients' dental status before treatment and the extent of dental treatment procedures were regarded significant.

Thus, more than 20 years ago, the departments of Radiotherapy and of Oral and Maxillofacial Surgery of the Saarland University Medical School together started a dental examination and rehabilitation program with the aim to prevent IORN as far as possible. All patients referred for radiotherapy for cancer in the oral cavity were examined by the oral and maxillofacial surgeon, the exact dental findings were recorded and -- if necessary, specific rehabilitation procedures were performed. Radiotherapy was started only after approval by the Oral and maxillofacial surgeon (OMF surgeon). After therapy, the patients were seen regularly by the radiooncologist, diagnosis and treatment of IORN were performed by the oral and maxillofacial surgeon.

After completion of two theses (Barbie [@CR2]; Mang [@CR25]), published in (Niewald et al. [@CR28]; Niewald et al. [@CR29]) each analyzing a ten years' period of radiotherapy for oral cancer one after the other, we now had the unique possibility to reanalyze and to compare the data obtained in this very long observation period in terms of dental findings, dental rehabilitation procedures and the frequency of IORN.

Methods {#Sec2}
=======

Two groups of patients who had undergone radiotherapy for neoplasms of the oral cavity have been reanalyzed retrospectively:

Group A consists of 90 consecutive patients having been treated in the years 1993-2003.

Group B consists of 114 consecutive patients having been treated in the years 1983-1992 (data in brackets).

All patients suffered from squamous cell carcinoma of the oral cavity mainly in stages III and IV according to the Union Internationale contre le Cancer-(UICC)-definition, one patient had a local recurrence but had not been irradiated before. Patients with treated local or regional recurrences, distant metastases or with insufficient data were excluded. In group B, it seemed impossible to actualize the follow-up data, so that the data from the former analysis were taken. For this reason, no comparison of oncological results was attempted. In order to improve comparability, the inclusion criteria mentioned above were applied to both groups retrospectively which lead to the exclusion of several patients and a complete re-analysis of the data.

70% of the patients in group A (85%, n.s.) had undergone surgery for the primary tumor and the regional lymph node regions. After surgery or after biopsy all patients were referred to the oral and maxillofacial surgeon for assessment of the dental status including an meticulous clinical and x-ray examination. The dental treatment procedures were performed as early as possible with a minimal time interval of 7-10 days from the last procedure to the beginning of radiotherapy. All dental extractions were performed according to a written protocol under "special care" (primary tissue closure, perioperative antibiotics for 7-10 days beginning one day before surgery). In the nineties all patients were advised not to wear their dental prostheses up to 6-12 months after radiotherapy (today until complete healing of mucositis) (Curi and Dib [@CR8]; Reuther et al. [@CR31]). Radiotherapy was started after complete healing of the gingival wounds and thus approval by the OMF surgeon.

After production of a face mask for fixation, the computerized tomography for radiotherapy planning was performed, and the two- dimensional (up to 2000) or three-dimensional dose distribution was computed after target volume delineation. Radiotherapy was applied using 4-6MV photons (electrons for level V lymph node region) of a linear accelerator; a 60-Cobalt machine was in use additionally until 1987. In the majority of patients (n = 73 in group A, n = 74 in group B), conventionally fractionated radiotherapy was applied with total doses of 60-70 Gy (details see Table [1](#Tab1){ref-type="table"}) in daily single fractions of 2 Gy. Furthermore, different hyperfractionated schedules were performed in both groups: in group A (n = 46) a total dose of 72 Gy was applied in single doses of 1.2 Gy twice daily (interfraction interval \> =6 hours) to patients with formerly untreated tumors, in group B (n = 41) a total dose of 82.8 Gy in single doses of 1.2 Gy twice daily (interfraction interval 4-6 hours) was applied to patients with untreated and with resected tumors. Two patients in group A have been treated in a different manner (one with 1.4 Gy twice daily, another with a single dose of 3.0 Gy once daily).Table 1**Biographical and oncological data**ItemGroup AGroup BRemarksMean age (years)57.154.6n.s.Mean Karnofsky performance Index7.87.5n.s.Follow-up (years)4.15.0p = 0.004T-stageT114 (16%)20 (18%)n.s.T233 (37%)49 (43%)T38 (9%)19 (16%)T435 (38%)26 (23%)N-stageN020 (22%)46 (40%)n.s.N123 (26%)24 (21%)N247 (52%)30 (26%)N3014 (13%)UICC stageI6 ( 7%)10 ( 9%)n.s.II7 (8%)22 (19%)III19 (21%)26 (23%)IV58 (64%)56 (49%)Pre-treatmentNone24 (27%)17 (15%)p \< 0.001Surgery66 (73%)97 (85%)Total dose (Gy)Conventional fractionationN = 75N = 73p \< 0.00130Gy (1)2Gy (1)36Gy (1)8Gy (1)50Gy (7)36Gy (1)58Gy (2)44Gy (1)60Gy (32)56Gy (1)64Gy (9)60Gy (31)70Gy (23)62Gy (1)66Gy (1)70Gy (31)72Gy (2)76Gy (1)80Gy (1)Total dose (Gy)HyperfractionationN = 15N = 4155.8Gy (1)13.2Gy (1)70.8Gy (1)81.6Gy (2)72.0Gy (11)82.8Gy (35)72.8Gy (1)85.2Gy (1)76.8Gy (1)85.5Gy (1)87.8Gy (1)Daily fractionConventional fractionation2.0 Gy (74)2.0Gy (73)p = 0.00123.0 Gy (1)Hyperfractionation1.2 Gy (14)1.2 Gy (41)1.4 Gy (1)Simultaneous chemotherapy140p \< 0.001

14(0) patients received chemotherapy consisting of cis-platinum and 5-FU simultaneously due to their unfavourable tumour and nodal stage. No patients with chemotherapy were excluded from the evalution. During therapy, the patients received dental care by the local dental colleagues. Fluoridation was used according to dental advice. Splints were not normally used because of unfavourable experience of patients with aggravating radiation mucositis by applying fluoride jelly to the gingiva using these splints.

After radiotherapy, the patients were examined for locoregional result and possible side effects in the Department of Radiotherapy and Radiooncology. Dental follow-up was performed by their local dentists. Consequently, detailed data about this phase are not available. Patients with a suspicion of IORN were referred to the Dept. of Oral and Maxillofacial Surgery for further diagnosis and treatment.

The mean duration of follow-up was 3.64 years (5 years, p = 0.004).

Infected osteoradionecrosis was minimally diagnosed when necrosis of the gingiva on top of the eroded bone became visible as infected mucosal ulcers with eroded mandibular bone underneath according to grade 2 or higher of the classification published by Schwartz et al. (Schwartz and Kagan [@CR33]). Patients with manifest IORN were treated by the oral and maxillofacial surgeon in cooperation with the local dentist.

The patients' data were collected from the records in the Departments of Radiotherapy and Radiooncology and Oral and Maxillofacial Surgery. All (panoramic x-ray) examinations available have been reviewed, thus we are quite sure that a potential local recurrence has not been misdiagnosed as an IORN. Furthermore, standardized questionnaires were mailed to the patients' general medical practitioners and general dentists as well as the local authorities five times within the observation period in order to get additional data about freedom of local or regional recurrence, survival or the onset of IORN.

All data were entered into a medical databank (Medlog™, Parox, Muenster, Germany). Frequency distributions, means and standard deviations were computed. The groups were compared using the t-test (means) and the Kruskal-Wallace test (distributions). Overall survival and occurrence of IORN over time were computed using the Kaplan-Meier estimate, the comparison of the groups was performed using the Mantel-Haenszel test. Prognostic parameters for IORN were analyzed univariately by comparison of means and distributions in a group containing the patients with IORN compared to another group with the patients who never experienced IORN using the t-test, u-test and chi-square test in the appropriate variables. Multivariate search for independent prognostic factors was performed by logistic regression.

Detailed biographical and oncological data have been summarized in Table [1](#Tab1){ref-type="table"}.

All patients had given their written informed consent before dental examination and treatment as well as radiotherapy. The approval by the local ethics committee was dispensable due to the retrospective nature of this evaluation. This research is in compliance with the Declaration of Helsinki in its actual version.

Results {#Sec3}
=======

General remarks {#Sec4}
---------------

In group A, up to July 2013, 58 patients were dead with a mean follow-up of 2.4 \[0-8.8\] years. The patients known to be alive were seen irregularly, the most recent information resulted from questionnaires, nearly all patients were lost to follow-up after on average 7.4 \[0-15\] years.

In group B, 77/114 patients were dead with a mean follow-up of 3.4 \[0-11.7\] years. The patients known alive were lost to follow-up after on average 8.5 \[4.3-13.3\] years.

Dental findings before radiotherapy {#Sec5}
-----------------------------------

The patients' dental status was generally poor. On average 10.1 (10.8) teeth were found present at the time of initial dental examination. For most of the criteria there was no statistically significant difference between the groups. However, we found significantly more destroyed teeth (1.4 vs. 0.3 teeth, p = 0.002) in the more recent patient collective, Furthermore there were more roots filled incompletely (0.3 vs. 0.1 teeth, p = 0.006). However, avital teeth were found less frequently in group A (0.5 vs. 1.0 teeth, p = 0.023). Chronic periodontitis with less to moderate attachment loss was found less frequently (p = 0.01) whereas chronic periodontitis with severe attachment loss was seen more frequently (p \< 0.001) in group A compared to group B. Detailed data have been depicted in Table [2](#Tab2){ref-type="table"}.Table 2**Dental findings before radiotherapy**Teeth (mean values, n=)Group AGroup BComparison:Data available from n patientsAbsent22.021.2n.s.204Present10.110.8n.s.204Carious2.02.3n.s.198Deeply carious destroyed1.40.3p = 0.002200Loose1.62.2n.s.197Root remainders0.30.4n.s.202Devital0.51.0p = 0.023200Roots -- filled completely0.20.1n.s.198Roots -- filled incompletely0.30.1p = 0.006199Apical periodontitis0.30.2n.s.200Dentogenic cysts0.20.1n.s.199Retained teeth0.20.1n.s.198Superficial marginal periodontitis (patients)- Localized7 (8%)33 (29%)p = 0.002199- General10 (11%)16 (14%)Profound marginal periodontitis (patients)- Localized12 (14%)25 (22%))p = 0.002201- General35 (40%)14 (12%)Superficial marginal periodontitis: chronic periodontitis with less to moderate attatchment loss.Profound marginal periodontitis: chronic periodontitis with severe attatchment loss.

We can summarize that dental status in these special patients has hardly changed over the decades. Data concerning dental biofilm or the use of dental prostheses had not been collected in group B, thus a comparison could not be performed.

Dental rehabilitation procedures {#Sec6}
--------------------------------

In the majority of criteria, the extent of dental rehabilitation procedures was identical in both groups. Tooth extractions were found more frequently in group B (3.7 vs. 5.8, p = 0.008) whereas conserving treatment was performed more frequently in Group A (0.6 vs. 0.1, p = 0.008). Detailed data are summarized in Table [3](#Tab3){ref-type="table"}.Table 3**Dental rehabilitation procedures**Teeth (mean values, n=)Group AGroup BComparisonData available from n patientsEndodontic treatment0.050.03n.s.200Removal of root remainders0.20.4n.s.200Tooth extraction3.75.8p = 0.008202Conserving treatment0.60.1p = 0.008200Cystectomy0.090.05n.s.199Surgical removal0.30.2n.s.201Healthy teeth remaining after dental rehabilitation6.24.8n.s.201

Frequency and risk factors of infected osteoradionecrosis (IORN) {#Sec7}
----------------------------------------------------------------

IORN was found in the corpus region of the mandible in 11/90 patients (12%) of group A and 22/114 patients (19%) of group B (n.s.). The one-year prevalence was 5%, the two- and three-year prevalence 15%. A subgroup analysis dividing the collectives into two groups each with the patients having been treated with conventional fractionation or with hyperfractionation yielded the following results:

After conventional fractionation IORN was found in group A in 11/74 patients (15%), in group B in 8/73 patients (11%, differences n.s.). After hyperfractionation, IORN was not diagnosed in group A wheras it was observed in 14/41 patients (34%) in group B (p = 0.01).

The Kaplan-Meier estimate showed that IORN normally occurred in the first two years in group A (first five years in group B) after radiotherapy (differences n.s.), after that time the risk remained stable (Figure [1](#Fig1){ref-type="fig"}). The subgroup analysis mentioned above resulted in identical curves for patients irradiated conventionally and highly different (but not statistically significant) curves after hyperfractionation.Figure 1**Development of IORN over time (Kaplan-Meier estimate)**.

The search for prognostically significant factors for the occurrence of IORN was performed using the whole patient collective consisting of 204 patients. The number of carious teeth, the N-stage, the total dose, the size of the daily fractions and the BED2 (Biologically effective dose 2 Gy) were found prognostically significant in univariate analysis. These factors were entered into the multivariate analysis where solely the number of carious teeth was found significant (details are depicted in Table [4](#Tab4){ref-type="table"}). The multivariate analysis showed the number of carious teeth a nearly significant prognostic factor, furthermore, the fractionation was found to be trendwise significant. All further factors mentioned in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"} tested univariately were found insignificant. Further details are depicted in Table [4](#Tab4){ref-type="table"}.Table 4**Prognostic factors for the occurrence of IORN (n = 204)**Univariate analysisTeethp=RemarksDental status before starting radiotherapyAbsent0.110Present0.107Carious0.026SignificantDeeply carious destroyed0.202Loose0.104Root remainders0.595Devital0.287Roots -- filled completely0.949Roots -- filled incompletely0.789Apical periodontitis0.888Cysts0.392Retained0.1620Conservative treatment possible0.430No conservative treatment possible0.179Filled0.751Not sufficiently filled teeth0.549Teeth with not sufficient crowns0.968ItemChronic periodontitis with less to moderate attatchment loss0.418LocalizedGeneralChronic periodontitis with severe attatchment loss0.210LocalizedGeneralDental treatment before radiotherapyEndodontic treatment0.379Removal of root remainders0.636Tooth extraction0.291Conserving treatment0.603Cystectomy0.936Healthy teeth remaining after dental rehabilitation0.158Demographic and oncological dataAge0.106Karnofsky performance status0.625T-stage0.222N-stage0.040SignificantTotal dose0.005SignificantBED20.040SignificantDaily fraction0.036Significant**Multivariate analysis**Carious teeth0.0089SignificantN-stage0.1256Total dose0.3524BED 20.4182Daily fraction0.5596All remaining factors as mentioned in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"} have been tested univariately and found insignificant, thus they were not tested multivariately.

We did not try to compare the oncological data like local and regional tumor outcome or survival because it seemed impossible to achieve reliable data for group B nearly 20 years after treatment. Thus, we could not correlate the frequency of IORN to a local recurrence.

Discussion {#Sec8}
==========

Dental health status and dental rehabilitation procedures {#Sec9}
---------------------------------------------------------

From our data we can summarize that -- despite all effort in dental prophylaxis -- the dental status of patients with oral neoplasms did not improve" over decades nor did the extent of dental rehabilitation procedures necessary before the start of radiotherapy.

The comparison of our data to those of the Forth German Trial of Oral Health (Kern et al. [@CR18]) resulted in marked differences: In this study adults (33-44 years of age) on average 14.5 teeth were found carious, in older people (\> = 45 years of age) 22.1 teeth. These teeth were rehabilitated completely in 95.6% and in 94.8%, respectively. A mean of 2.77 teeth in adults and of 14.2 teeth in older people were missing. 72% of the adults and 60.6% of the seniors were found to perform sufficient mouth hygiene. All these values were improved compared to the results of a former trial in 1997. On the other hand, the frequency of periodontitis was rising (moderate in 52.9% and intense in 39.8% of the population). Compared to those data our findings in patients with oral neoplasms were much more unfavourable and did not improve over time.

Further equally detailed analyses were rare. Jham et al.(Jham et al. [@CR16]) reported in 2008 a collective of 207 patients with head and neck cancer with similar dental findings to our investigation detecting periodontal disease in 41%, retained roots in 21%, carious teeth in 12%, and unerupted teeth in 5.8% of their patients, resulting in an IORN rate of 5.5%. Schuurhuis et al. summarized 2011 the data of 185 patients and found oral infectious foci in 75%, a periodontal pocket depth of more than 6 mm in 23%, severe caries in 4%, impacted teeth in 4%, and residual root tips in 3%. Tooth extractions had to be performed in 30% of the patients, a mean of 7.7 teeth had to be removed. Periodontal treatment was performed in 6%. IORN was diagnosed in 11% (Schuurhuis et al. [@CR32]). Further literature data on this topic have been summarized in Table [5](#Tab5){ref-type="table"}. In general, tumor patients frequently showed a noncompliance in routine dental care and daily oral hygiene. Tumor diagnosis did not change the patients' habits: Lockhart and Clark stated in 1994 that 97% of their patients needed dental care before radiotherapy, but only 81% underwent the indicated treatment.Table 5**Dental status and rehabilitation procedures in the literature for IORN in the lower jaw**Author groupDental statusRehabilitation proceduresRemarksFrydrych and Slack-Smith [@CR10] (n = 82)No informationNo informationAverage (median) date of last dental visit: 66.76 months (18 months) before radiotherapyGuggenheimer and Hoffman [@CR14] (n = 947)Edentulous: 59%No informationPartially edentulous: 9%Poor dentition with no replacement: 14%Intact dentition: 18%Maier et al. [@CR24] (n = 100)Tumour vs. control patients: Tartar \> 3 mm: 40.91 vs. 21.98%No informationTumour vs. control patientsNever tooth brushing 44.9 vs. 23.5%Decayed teeth \>50% : 27.2 vs. 3.9%Dental visit more than once a year: 6% vs. 43.5%Lockhart and Clark [@CR22] (n = 131)Alveolar bone loss: 66%Needing dental care: 97%Noncompliant with routine dental care: 76%Clinical caries: 71%Did not seek the indicated treatment: 81%Noncompliant with routine oral hygiene: 65%Failing restorations: 91%Jham et al. [@CR16] (n = 207)Periodontal disease: 41%No informationResidual root: 21.2%Caries 12%Unerupted tooth: 5.8%

Frequency of IORN {#Sec10}
-----------------

The frequency of IORN was almost equal in both groups. However, the influence of fractionation was interesting. The rates of IORN were identical after conventional fractionation over the decades. However, while in group B an unacceptably high amount of IORN was diagnosed after hyperfractionation, we did not see any IORN in group A. One reason may be the reduction of the total dose from 82.8 Gy to 72 Gy, another one the extension of the interfraction interval from 4-6 to generally \>6 hours, this relevance of interfractional time intervals for cell recovery was not yet known during radiotherapy of group B patients (Fowler, J., personal communication, approx. 1988).

In the literature, the incidence of IORN varied widely (0-74%) as depicted in Table [6](#Tab6){ref-type="table"} whereas the majority of data are in a range of 5-10%. However, the comparison of these values to each other and to our results is very difficult because of a different definition of staging of IORN, different tumor localizations, therapy schedules, radiation techniques and dosages results fit well within the range of data taken from the literature (Kim et al. [@CR19]; Niewald et al. [@CR28]). One of the data sets in the literature most comparable to our dataset has been published by Lee et al. (Lee et al. [@CR20]) who experienced comparable IORN frequencies in a collective of patients having been operated on mainly.Table 6**Incidence of IORN of the upper and lower jaw in the literature**Author groupIncidenceRemarksBen-David et al. [@CR3] (n = 176)0Multiple tumour localizationsPrimary treatment (no surgery)IMRT108/176 radiochemotherapyBerger and Bensadoun [@CR4]1-5%Literature surveyCrombie et al. [@CR7] (n = 54)36%53/54 radiochemotherapyGomez et al. [@CR13] (n = 168)1.2%Multiple tumour localizationsIMRTGomez et al. [@CR12] (n = 35)5%IMRTJereczek-Fossa and Orecchia [@CR15]0.4-56%Literature surveyJham et al. [@CR16] (n = 207)5.5%Head and neck cancerKatsura et al. [@CR17] (n = 39)15%Lee et al. [@CR20] (n = 189)6.6%Oral cavity and oropharynxMonnier et al. [@CR26] (n = 73)40%Oral cavity and oropharynxOh et al. [@CR30] (n = 81)4.9%Reuther et al. [@CR31] (n = 830)8.2%Oral cavity and oropharynxStenson et al. [@CR34] (n = 27)18.4%Surgery, adjuvant radiochemotherapyStorey et al. [@CR36] (n = 83)6%Malignant submandibular tumoursStuder et al. [@CR37] (n = 304)Grade 2 EORTC: 1.6%Oral cavity and oropharynxConventional dental care vs. risk-adapted dental careIMRTThiel [@CR38]4-35%Literature surveyThorn et al. [@CR39] (n = 80)74%/3 yearsMultiple tumour localizationsTsai et al. [@CR40] (n = 402)7.5%Oropharyngeal cancer, median time to IORN 8 monthsTurner et al. [@CR41] (n = 333)5.9%

Risk factors for the occurrence of IORN {#Sec11}
---------------------------------------

Numerous prognostic factors for the development of IORN have been tested and published. A selection of these is summarized in Table [7](#Tab7){ref-type="table"}. The localization of the primary tumor in the oral cavity with its microbial colonization and the abundant involvement of the mandibular bone with its unique blood supply probably promotes IORN. Unfavorable dental status, periodontal disease and soreness of the gingiva by pressure triggered by dental prosthesis are important as well as dental extractions before and especially after radiotherapy.Table 7**Risk factors for IORN of the upper and lower jaw in the literature**Author groupRisk factor(s)RemarksAhmed et al. [@CR1]Intensity modulated radiotherapy (IMRT) advantageous compared to conventional radiotherapyBerger and Bensadoun [@CR4]Total dose \>66 GyLiterature surveyBhide et al. [@CR5]Total dose \> 60 GyLiterature surveyVolume of mandible within the treatment field. Trauma related ORN after lower dosesIMRTChopra et al. [@CR6]White ethnicitySecondary infectionAdvanced ageStage IVTotal dosePost-RT dental extractionsLack of pre-RT dental extractionsCuri and Dib [@CR8], [@CR9]Oral cancerInvasion of boneTumour surgeryTotal radiation doseDose rate/dayMode of radiation deliveryDental statusTime from radiation therapy until the onset of ORNGoldwasser et al. [@CR11]Higher body mass indexMultivariate analysisUse of steroidsRadiation dose \>66 GyJereczek-Fossa and Orecchia [@CR15]Total doseLiterature survey, only part of the factions mentioned in the paper cited hereBrachytherapy doseDose per fractionInterval between fractionsVolume of the horizontal ramus of the mandible irradiated with a high doseDental statusBad oral hygieneDental extractions after radiotherapyKatsura et al. [@CR17]Oral health status after radiotherapyPeriodontal pocket depthDental plaqueAlveolar bone loss levelRadiographic periodontal statusLee et al. [@CR21]Univariate: Mandibular surgeryMultivariate analysis:Co-60Mandibular surgeryBED \>106.2 GyLozza et al. [@CR23]Dose rateBrachytherapy exclusivelyReference volumeMonnier et al. [@CR26]Oral cavity tumoursMultivariate analysis: bone surgeryBone invasionSurgery prior to radiotherapyBone surgeryNabil [@CR27]HyperfractionationLiterature surveyReduced risk after accelerated radiotherapy with reduced doseReuther et al. [@CR31]Advanced tumoursSegmental resection of the mandibleTooth extractions (pre/post RT)Pre-surgical radiotherapy worse than post-surgical radiotherapyStore and Boysen [@CR35]Tumour localization in tongue and floor of mouthTraumaThiel [@CR38]CariesPeriondontosisPeriapical pathologyInjuryIrritation by prosthesesDental extractions before and after radiotherapyBone surgery because of remaining or recurrent tumoursThorn et al. [@CR39]Removal of teethSurgeryInjury from prosthesisSpontaneous breakdownsTsai et al. [@CR40]Total doseDental statusSmokersAlcoholLarger tumoursTurner et al. [@CR41]Bone involvementSynchronous MethotrexateScattered dose from elective neck treatmentIncreasing doseIncreasing target volumes for doses \<55 GyDental extractions

Radiation dose should not exceed 60 -- 66 Gy to the mandibular bone whenever possible, the target volume extending to the bone should be limited. Some authors regard hyperfractionation as a risk factor for IORN. In our ancient publication on this topic (Niewald et al. [@CR28]) we experienced a very high frequency of IORN after hyperfractionated radiotherapy which may have been caused by too high total doses on the one hand and a too short interfraction interval (time interval between the two daily fractions) on the other hand. Both factors have been taken into account since 1992, consequently the results were improved markedly.

Intensity modulated radiotherapy (IMRT) has been found advantageous compared to conventional 3D-planned radiotherapy. Additional factors may be chemotherapy, higher body mass index and the use of steroids.

An important paper has been published by Tsai et al. in 2013 (Tsai et al. [@CR40]). They reviewed the records of patients with small oropharyngeal cancers having undergone radiotherapy or radiochemotherapy. The overall prevalence of IORN was 7.5%, higher doses, use of nicotine and alcohol, dental status as well as more advanced tumors were found significant risk factors for the development of IORN. In contrast to this paper our patients' primary situation seems more unfavorable: we only examined patients with oral cancer where the whole mandible was within the 100%-isodose, thus we applied even higher doses to a large amount of bone. Furthermore, older techniques have been used; unfortunately, no information about fractionation has been given. Consequently, a higher prevalence of IORN here seems to be explainable.

Unfortunately, we did not succeed in identifying clearly significant independent prognostic factors for the development of IORN. In our patient collective, hyperfractionation seemed to have a protective effect whereas this could not be examined further due to the small number of events. In our dataset the number of carious teeth was found to be the only independent prognostic factor after multivariate analysis. Univariately, total dose and BED2 were significant which could be expected. In majority of patients, the total doses lie in a narrow range of 60-82 Gy which may have been a reason for the result, additionally the fact that few IORN cases have been observed.

The authors are well aware of the limitations of this retrospective evaluation. In this nearly homogenous collective of patients with oral cavity cancer having undergone radiotherapy +/- surgery, we have found complete data sets with respect to the dental status and restoration procedures of nearly all patients. The IORN data have been investigated meticulously, but due to the known incompliance of head and neck patients we could not exclude that single events did not become known to the authors.

Conclusions {#Sec12}
===========

The patients' dental status before radiotherapy was very poor compared to an otherwise healthy population. Apparently we did not succeed in improving these findings over the decades despite all effort in terms of dental prophylaxis. Consequently, extensive dental rehabilitation procedures had to be performed which did not change over time as well.

Examining patients irradiated with conventional fractionation, the incidence of IORN was found constant in a range of 10-15% over time. As stated earlier, the influence of the interfraction interval and of very high doses became known after the patients in group B had been irradiated, we thus diagnosed an unacceptably high frequency of IORN which became virtually zero after reduction of the total dose and extension of the interfraction interval. The multivariate search for prognostic factors only resulted in the assumption that dental status and fractionation could influence the occurrence of IORN.
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